Patient needs in advanced Renal Cell Carcinoma: What are patients’ priorities and how well are we meeting them?
Treatment options and duration of therapy for patients with metastatic renal cell carcinoma (mRCC) have increased. Many patients now spend in excess of 2 years on active therapy. These patients’ needs, and the ability of health services to respond to them, are poorly understood. Ten patients living...
Guardado en:
| Autores principales: | , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
The Beryl Institute
2015
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/86c07aa0dc4446b4bad3b04f662880d1 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|